Concerns about readiness of the European Medicines Agency’s (EMA) Clinical Trials Information System persist as the.

The largest pharmaceutical companies not surprisingly rely on the largest contract research organizations

The proceedings of the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI)

Welcome to the second issue of the Refractory Asthma Stratification

There have been hundreds of thousands of deaths from COVID-19

Clinical trials are not cheap to conduct, and with data integrity

MID‐Frail News returns with this Special Issue to report on the project development

If you have been involved in the pharmaceutical industry for any length

High functioning investigator sites are essential to the delivery

I am shamelessly referencing our Insider’s Insights (IIs) to Dr Who’s TARDIS – our latest edition

Our publication on the potential benefits of bariatric surgery

You may think that 'writing the abstract' simply  involves summarising

Welcome to the latest edition of the Frailomic Initiative Newsletter.

Welcome to the latest issue of the Refractory Asthma Stratification Programme (RASP-UK)

Last night saw a collection of the UK’s great and the good in clinical pharmacology

All of our core studies have now completed their clinical phase

The New Year started excellently for MID-Frail with the first patients

Attend any research meeting, conference or clinical congress

Many scientists believe that we have reached the end of the life-expectancy revolution

Metathesiophobia: from Preclinical to Clinical Development

Advisory board meetings are often used to address perceived knowledge gaps and build consensus.

Having worked in early-stage clinical pharmacology for over 30 years

It was encouraging to see so many partners at the 2017 General Assembly meeting last December

Ask anyone and they will tell you that they don’t think they are as old as they are.

When the UK went into lockdown on March 23rd because of the COVID-19 outbreak,

The US Army has a new secret weapon – napping.

Read the latest newsletter from both our MID-Frail

Investigator-Initiated Clinical Trials (IITs) are clinical studies led by academic researchers or clinicians

The sudden imposition of remote working in response to the 2020 COVID-19

In the UK we have a saying that you wait hours for a bus and then two come along at once.

We've been sharing you our Insider's Insights with you for 2 years now.

Deep Breath is the official newsletter of the UKs Refactory Asthma

Today we had our manuscript on the pre-protein convertase subtilisin kexin (PCSK)-9

Research into the remarkable regenerative powers of the flatworm Macrostomum lignano a

The world's first human COVID challenge trial has been given the green light

The clinical stage biotechnology company developing breakthrough therapies for patients suffering with cancer,

The latest issue of Journal Frontiers in Pharmacology has just published

In 1786, estimates placed our average life expectancy at just 24 years.

Phenotype-specific omic expression patterns in people with frailty could provid

As a jobbing scientist you rarely spend your whole career working on the same project.

Many of the increasing number of elderly in our population

Our group of academic and industry partners won a big MRC grant yesterday

Read the latest newsletter here [1]. In this edition

ive years ago I was lucky enough to be involved in a project that resulted in publications

2012 has been a very busy year for the MID-Frail partners and the study consortium

The EUropean Federation for Exploratory MEdicines Development (EUFEMED

Our publication on sarcoidosis, a multisystem inflammatory disease

When I was younger, the opening lines of the Beatle’s seminal ‘Sgt. Pepper’s Lonely Hearts Club Band’ resonated.

Frailty has a dramatic impact on the quality of life of many elderly people

Welcome to the Frailomic Newsletter Update for 2016.

Early in 2020, COVID-19 was spreading rapidly across the globe.

Here are a few lists of the best of the best over the last 12 months.

Our publication on new therapies in the management of type 2 diabetes mellitus

Frights create a happy Halloween by providing the thrill of fear in a controlled and safe environment, turning what.

This essential reading provides readers with a round-up of news on the latest events

We are pleased to bring you the latest edition of the MID-Frail newsletter

In its recent white paper on severe asthma, The Severe Asthma Report 2017

According to many observers we are standing on the precipice

Unfortunately, health does not generally improve with age.

The world's first human COVID challenge trial has been given the green light

Metathesiophobia: from Preclinical to Clinical Development

Whether it’s a festival, concert or celebratory party, music unites people and pervades

RASP-UK underwent its third progress review by the MRC on 19 May.

Have you seen our latest Insider's Insight on Case Reports? Once a staple of medical journals,

Experience at Niche has taught us that clinical study protocols are born in the white-hot fire

Our publication on effectiveness of a multimodal intervention

Phase I is the lifeblood or new medicines. The UK’s Phase I representative body,

Niche Science & Technology Ltd. are leading the team today awarded a Euro 7.5M

ur publication on new therapies to reduce low-density

However you may feel about the way political leaders have turned Brexit

You can now download our latest newsletter, detailing how 2014

We are looking over the precipice that is a revolution in lifespan modification.

Investigator sites are very important to clinical studies because they make sure that new drugs are safe and work well.

The UK's world-class human challenge study gives us new information about SARS-CoV-2 cases that were mild in 36 healthy.

The world's first human COVID challenge trial has been given the green light

Every year, a huge amount of scientific data is released. It's out there, but how do you find it?

Because new biologic treatments for asthma can be expensive and cause side effects,

If you're managing a project, it's important to stay informed about work progress

We are looking over the precipice that is a revolution

The comparison of the DPP4 (dipeptidyl peptidase 4) SARS-CoV-2

May 4 is often known as ‘Star Wars Day’. It is jokingly said

Epidemiological data suggest that at two in five of us will experience

Download the third issue of the Refractory Asthma Stratification

With age comes wisdom, however the physical side of ageing

In this case the plan is a paradigm shift in the way we will manage

We all have a responsibility to encourage young people to study science

Asthma is a chronic inflammatory disorder of the airways

Do you know what Good Laboratory Practice stands for? In nonclinical animal studies

Rational Vaccines (RVx) announces MHRA Innovation Licensing and Access Pathway (ILAP) approval for their live attenuated.